Great Lakes Advisors LLC purchased a new stake in shares of Calumet, Inc. (NASDAQ:CLMT – Free Report) during the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 169,195 shares of the oil and gas company’s stock, valued at approximately $3,088,000.
A number of other institutional investors also recently bought and sold shares of CLMT. Two Seas Capital LP grew its holdings in shares of Calumet by 56.9% during the 2nd quarter. Two Seas Capital LP now owns 4,497,609 shares of the oil and gas company’s stock worth $70,860,000 after acquiring an additional 1,631,098 shares during the period. Geode Capital Management LLC lifted its stake in shares of Calumet by 112.4% in the 2nd quarter. Geode Capital Management LLC now owns 1,704,670 shares of the oil and gas company’s stock valued at $26,860,000 after purchasing an additional 901,933 shares during the period. AYAL Capital Advisors Ltd bought a new stake in shares of Calumet during the second quarter valued at approximately $5,278,000. BNP Paribas Financial Markets grew its stake in Calumet by 18,512.3% in the second quarter. BNP Paribas Financial Markets now owns 183,890 shares of the oil and gas company’s stock worth $2,897,000 after purchasing an additional 182,902 shares during the period. Finally, Diametric Capital LP purchased a new stake in Calumet in the second quarter worth $2,312,000. 34.41% of the stock is owned by institutional investors.
Calumet Price Performance
NASDAQ CLMT opened at $22.41 on Friday. The stock has a market capitalization of $1.94 billion, a price-to-earnings ratio of -52.12 and a beta of 1.23. Calumet, Inc. has a 1-year low of $7.68 and a 1-year high of $23.00. The business’s fifty day moving average price is $20.05 and its 200-day moving average price is $18.38.
Wall Street Analysts Forecast Growth
CLMT has been the topic of a number of research reports. Wall Street Zen cut shares of Calumet from a “buy” rating to a “hold” rating in a report on Sunday, December 14th. TD Cowen reaffirmed a “hold” rating on shares of Calumet in a research note on Thursday. The Goldman Sachs Group boosted their price target on Calumet from $20.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday. Zacks Research upgraded Calumet from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th. Finally, HC Wainwright reiterated a “buy” rating and set a $33.00 price objective on shares of Calumet in a research note on Monday, November 10th. Four research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $20.71.
Check Out Our Latest Research Report on CLMT
Calumet Company Profile
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Further Reading
- Five stocks we like better than Calumet
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Want to see what other hedge funds are holding CLMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Calumet, Inc. (NASDAQ:CLMT – Free Report).
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
